Director Jeff Haywood exits Definitive Healthcare (DH) board, shrinking seats
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Definitive Healthcare Corp. reported that on March 30, 2026, director Jeff Haywood resigned from its Board of Directors and from the Board’s Human Capital Management and Compensation Committee, effective immediately. The company stated that his resignation was not due to any disagreement regarding its operations, policies, or practices.
Following his departure, the Board size was reduced from nine members to eight members, and the Compensation Committee was reduced from three members to two members, reflecting his departure rather than adding a replacement director at this time.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Board size before resignation: 9 members
Board size after resignation: 8 members
Compensation Committee size before: 3 members
+2 more
5 metrics
Board size before resignation
9 members
Board of Directors size prior to March 30, 2026
Board size after resignation
8 members
Board of Directors size following Jeff Haywood’s resignation
Compensation Committee size before
3 members
Human Capital Management and Compensation Committee prior to resignation
Compensation Committee size after
2 members
Committee size following Jeff Haywood’s departure
Resignation effective date
March 30, 2026
Effective date of Jeff Haywood’s resignation
Key Terms
Human Capital Management and Compensation Committee, Emerging growth company, Class A Common Stock, The Nasdaq Stock Market LLC
4 terms
Human Capital Management and Compensation Committee financial
"and as a member of the Human Capital Management and Compensation Committee (the “Compensation Committee”)"
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Class A Common Stock financial
"Class A Common Stock, $0.001 par value | | DH | | The Nasdaq Stock Market LLC"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
The Nasdaq Stock Market LLC market
"DH | | The Nasdaq Stock Market LLC"
The Nasdaq Stock Market LLC is a major U.S. stock exchange that provides the platform and rules for buying and selling shares of public companies, similar to a busy online marketplace where buyers and sellers meet. It matters to investors because it determines where a stock trades, helps set prices through supply and demand, and enforces listing and reporting standards that affect a company’s visibility, liquidity and regulatory oversight.
FAQ
What board change did Definitive Healthcare (DH) disclose in this 8-K?
Definitive Healthcare disclosed that director Jeff Haywood resigned from its Board of Directors on March 30, 2026. His departure also triggered a reduction in the overall Board size from nine directors to eight directors, aligning the structure with the current membership.
Did Jeff Haywood’s resignation from Definitive Healthcare (DH) involve any disagreement?
The company stated that Jeff Haywood’s resignation was not due to any disagreement with Definitive Healthcare regarding its operations, policies, or practices. This language signals a routine governance change rather than a dispute-driven departure from the Board.
How did Jeff Haywood’s resignation affect Definitive Healthcare’s Compensation Committee?
When Jeff Haywood resigned, he also left the Human Capital Management and Compensation Committee. As a result, the committee size was reduced from three members to two members, reflecting his departure rather than appointing a new committee member immediately.
What is Definitive Healthcare’s current Board size after the March 30, 2026 change?
After Jeff Haywood’s resignation on March 30, 2026, Definitive Healthcare’s Board of Directors was reduced from nine members to eight members. This adjustment simply aligns the Board size with the remaining directors serving at the company.
Which executive signed this Definitive Healthcare (DH) 8-K filing?
The 8-K was signed on behalf of Definitive Healthcare by Casey Heller, the company’s Chief Financial Officer. The signature confirms that an authorized executive reviewed and approved the disclosure describing the Board and committee changes.